25
Jul

Keryx Biopharmaceuticals’ in-development Zerenex helped reduce dangerous buildups of phosphorus in patients on kidney dialysis, meeting its goals in a Phase III study as the company awaits final word from the FDA.

…read more

Source: Keryx touts its kidney drug with an FDA decision around the corner

    

0 No comments